Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. https://doi.org/10.1056/NEJMoa043330

Article  CAS  PubMed  Google Scholar 

Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18:170–186. https://doi.org/10.1038/s41571-020-00447-z

Article  PubMed  Google Scholar 

McBain C, Lawrie TA, Rogozińska E, Kernohan A, Robinson T, Jefferies S (2021) Treatment options for progression or recurrence of glioblastoma: a network meta-analysis. Cochrane Database Syst Rev 5:CD013579. https://doi.org/10.1002/14651858.CD013579.pub2

Article  PubMed  Google Scholar 

Schupper AJ, Chanenchuk T, Racanelli A, Price G, Hadjipanayis CG (2022) Laser hyperthermia: past, present, and future. Neuro Oncol 24:S42–51. https://doi.org/10.1093/neuonc/noac208

Article  PubMed  PubMed Central  Google Scholar 

Xue Z, Guan X, Yuan L, Kang P, Zhang C, Li D et al (2023) Laser interstitial thermal therapy in the treatment of brain metastases: the relationship between changes in postoperative magnetic resonance imaging characteristics and tumor recurrence. Acta Neurochir (Wien) 165:1379–1387. https://doi.org/10.1007/s00701-023-05504-x

Article  PubMed  Google Scholar 

Van Gompel JJ, Burkholder DB, Parker JJ, Grewal SS, Middlebrooks EH, Lehman VT et al (2023) Laser interstitial thermal therapy for Epilepsy. Neurosurg Clin N Am 34:247–257. https://doi.org/10.1016/j.nec.2022.11.005

Article  PubMed  Google Scholar 

Shah AH, Burks JD, Buttrick SS, Debs L, Ivan ME, Komotar RJ (2019) Laser interstitial thermal therapy as a primary treatment for deep inaccessible gliomas. Neurosurgery 84:768–777. https://doi.org/10.1093/neuros/nyy238

Article  PubMed  Google Scholar 

Fadel HA, Haider S, Pawloski JA, Zakaria HM, Macki M, Bartlett S et al (2022) Laser interstitial thermal therapy for first-line treatment of surgically accessible recurrent glioblastoma: outcomes compared with a Surgical Cohort. Neurosurgery 91:701–709. https://doi.org/10.1227/neu.0000000000002093

Article  PubMed  Google Scholar 

Brandes AA, Tosoni A, Franceschi E, Sotti G, Frezza G, Amistà P et al (2009) Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation with MGMT promoter methylation status. J Clin Oncol 27:1275–1279. https://doi.org/10.1200/JCO.2008.19.4969

Article  CAS  PubMed  Google Scholar 

Lerner EC, Edwards RM, Wilkinson DS, Fecci PE (2022) Laser ablation: heating up the anti-tumor response in the intracranial compartment. Adv Drug Deliv Rev 185:114311. https://doi.org/10.1016/j.addr.2022.114311

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schildkopf P, Ott OJ, Frey B, Wadepohl M, Sauer R, Fietkau R et al (2010) Biological rationales and clinical applications of temperature controlled hyperthermia–implications for multimodal cancer treatments. Curr Med Chem 17:3045–3057. https://doi.org/10.2174/092986710791959774

Article  CAS  PubMed  Google Scholar 

Man J, Shoemake JD, Ma T, Rizzo AE, Godley AR, Wu Q et al (2015) Hyperthermia sensitizes glioma stem-like cells to Radiation by inhibiting AKT Signaling. Cancer Res 75:1760–1769. https://doi.org/10.1158/0008-5472.CAN-14-3621

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang H, Zeng W, Ren X, Cui Y, Li M, Yang K et al (2019) Super-early initiation of temozolomide prolongs the survival of glioblastoma patients without gross-total resection: a retrospective cohort study. J Neurooncol 144:127–135. https://doi.org/10.1007/s11060-019-03211-1

Article  CAS  PubMed  Google Scholar 

Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972. https://doi.org/10.1200/JCO.2009.26.3541

Article  PubMed  Google Scholar 

Freites-Martinez A, Santana N, Arias-Santiago S, Viera A (2021) Using the common terminology criteria for adverse events (CTCAE - version 5.0) to evaluate the severity of adverse events of Anticancer therapies. Actas Dermosifiliogr (Engl Ed) 112:90–92. https://doi.org/10.1016/j.ad.2019.05.009

Article  CAS  PubMed  Google Scholar 

Mittal S, Klinger NV, Michelhaugh SK, Barger GR, Pannullo SC, Juhász C (2018) Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies. J Neurosurg 128:414–421. https://doi.org/10.3171/2016.9.JNS16452

Article  CAS  PubMed  Google Scholar 

Sarkaria JN, Hu LS, Parney IF, Pafundi DH, Brinkmann DH, Laack NN et al (2018) Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. Neuro Oncol 20:184–191. https://doi.org/10.1093/neuonc/nox175

Article  CAS  PubMed  Google Scholar 

Salehi A, Paturu MR, Patel B, Cain MD, Mahlokozera T, Yang AB et al (2020) Therapeutic enhancement of blood-brain and blood-tumor barriers permeability by laser interstitial thermal therapy. Neurooncol Adv 2:vdaa071. https://doi.org/10.1093/noajnl/vdaa071

Article  PubMed  PubMed Central  Google Scholar 

Leuthardt EC, Duan C, Kim MJ, Campian JL, Kim AH, Miller-Thomas MM et al (2016) Hyperthermic laser ablation of recurrent glioblastoma leads to Temporary disruption of the Peritumoral Blood Brain Barrier. PLoS ONE 11:e0148613. https://doi.org/10.1371/journal.pone.0148613

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee SY (2016) Temozolomide resistance in glioblastoma multiforme. Genes Dis 3:198–210. https://doi.org/10.1016/j.gendis.2016.04.007

Article  PubMed  PubMed Central  Google Scholar 

Li H, Cui X, Zhang J, Lin S (2014) Chemotherapy alleviates subacute recurrent glioma-associated refractory cerebral edema by downregulating vascular endothelial growth factor. Med Oncol 31:13. https://doi.org/10.1007/s12032-014-0013-9

Article  CAS  PubMed  Google Scholar 

Zhao X, Li R, Guo Y, Wan H, Zhou D (2024) Laser interstitial thermal therapy for recurrent glioblastomas: a systematic review and meta-analysis. Neurosurg Rev 47:159. https://doi.org/10.1007/s10143-024-02409-w

Article  PubMed  Google Scholar 

Shah AH, Semonche A, Eichberg DG, Borowy V, Luther E, Sarkiss CA et al (2020) The role of laser interstitial thermal therapy in Surgical Neuro-Oncology: Series of 100 consecutive patients. Neurosurgery 87:266–275. https://doi.org/10.1093/neuros/nyz424

Article  PubMed  Google Scholar 

Thomas JG, Rao G, Kew Y, Prabhu SS (2016) Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma. Neurosurg Focus 41:E12. https://doi.org/10.3171/2016.7.FOCUS16234

Article  PubMed  Google Scholar 

de Groot JF, Kim AH, Prabhu S, Rao G, Laxton AW, Fecci PE et al (2022) Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent IDH wild-type glioblastoma. Neurooncol Adv 4:vdac040. https://doi.org/10.1093/noajnl/vdac040

Article  PubMed  PubMed Central  Google Scholar 

Beaumont TL, Mohammadi AM, Kim AH, Barnett GH, Leuthardt EC (2018) Magnetic resonance imaging-guided laser interstitial thermal therapy for Glioblastoma of the Corpus Callosum. Neurosurgery 83:556–565. https://doi.org/10.1093/neuros/nyx518

Article  PubMed  PubMed Central  Google Scholar 

Butt OH, Zhou AY, Huang J, Leidig WA, Silberstein AE, Chheda MG et al (2021) A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma. Neurooncol Adv 3:vdab164. https://doi.org/10.1093/noajnl/vdab164

Article  PubMed  PubMed Central  Google Scholar 

Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM et al (2016) Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol 18:1199–1208. https://doi.org/10.1093/neuonc/now058

Article  CAS